Serious adverse events · Induction of Remission in Medically Refractory Crohn's Disease
Summary of findings table ‐ Stem Cell showed no clear difference in serious Adverse Events compared with placebo or Control (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Induction of Remission in Medically Refractory Crohn's Disease
It is very uncertain whether summary of findings table ‐ Stem Cell changes withdrawal due to adverse events compared with placebo or Control (very low certainty).
1 finding from 1 review
Intervention not reported
Overall survival (at 36 months) · patients after allogeneic stem cell or bone marrow transplantation
The intervention showed no clear difference in overall survival (at 36 months) (moderate certainty).
1 finding from 1 review
Intervention not reported
Acute GVHD II to IV (90 days) · patients after allogeneic stem cell or bone marrow transplantation
The intervention leads to lower acute GVHD II to IV (90 days) (high certainty).
1 finding from 1 review
Intervention not reported
Overall Chronic GVHD (up to 36 months) · patients after allogeneic stem cell or bone marrow transplantation
The intervention leads to lower overall Chronic GVHD (up to 36 months) (high certainty).
1 finding from 1 review
Intervention not reported
Incidence of relapse (up to 36 months) · patients after allogeneic stem cell or bone marrow transplantation
The intervention showed no clear difference in incidence of relapse (up to 36 months) (moderate certainty).
1 finding from 1 review
Intervention not reported
Non‐relapse mortality (at 36 months) · patients after allogeneic stem cell or bone marrow transplantation
The intervention showed no clear difference in non‐relapse mortality (at 36 months) (moderate certainty).
1 finding from 1 review
Intervention not reported
Graft failure (during study) · patients after allogeneic stem cell or bone marrow transplantation
The intervention showed no clear difference in graft failure (during study) (low certainty).
1 finding from 1 review
Intervention not reported
Adverse Events (during study) · patients after allogeneic stem cell or bone marrow transplantation
1 finding from 1 review
Intervention not reported
Response  · children and adolescents with acute graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Overall survival · children and adolescents with acute graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Relapse‐free survival · children and adolescents with acute graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Adverse events · children and adolescents with acute graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Quality of life · children and adolescents with acute graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Cost of intervention per month · children and adolescents with acute graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Response · children and adolescents with chronic graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Overall survival · children and adolescents with chronic graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Failure‐free survival · children and adolescents with chronic graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Adverse events · children and adolescents with chronic graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review
Intervention not reported
Quality of life · children and adolescents with chronic graft‐versus‐host disease after haematopoietic stem cell transplantation
1 finding from 1 review